It has been previously proposed that SDF-1α/CXCR4 signalling played role in AT-MSC homing within the sites of tumor formation and recently published data have demonstrated that inhibition of this axis by small molecule inhibitor AMD3100 could abrogate their migration towards prostate cancer cells [44]. The gene discussed is CXCL12; the disease is neoplasm.